Prokidney (PROK) Cash from Operations (2021 - 2026)
Prokidney's (PROK) quarterly Cash from Operations came in at 41684000.0 in Q1 2026, down 40.86% year-on-year from 70486453.03 in Q1 2025, and down 28.21% on a QoQ basis from 32513000.0 in Q4 2025.
Prokidney (PROK) Cash from Operations (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Cash from Operations data on file, last reported at 41684000.0 in Q1 2026.
- On a quarterly basis, Cash from Operations fell 40.86% year-over-year to 41684000.0 in Q1 2026; TTM through Mar 2026 was 132209000.0, a 9.0% decrease from a year earlier, with the FY2025 full-year figure at 120117000.0, up 4.93% from the prior year.
- Cash from Operations for Q1 2026 stood at 41684000.0, down from 32513000.0 in the prior quarter.
- Over the last five years, Cash from Operations for PROK reached as high as 14916000.0 in Q2 2023 and fell as low as 41684000.0 in Q1 2026.
- Historically, Cash from Operations has averaged 26782941.18 across 5 years, with a median of 25992000.0 in 2023.
- Across the five-year window, Cash from Operations tumbled 115976.02% in 2022 and jumped 35.22% in 2023, its largest moves.
- Year by year, Cash from Operations stood at 15761000.0 in 2022, then tumbled by 61.06% to 25384000.0 in 2023, then rose by 4.78% to 24171000.0 in 2024, then plunged by 34.51% to 32513000.0 in 2025, then declined by 28.21% to 41684000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were 41684000.0 in Q1 2026, 32513000.0 in Q4 2025, and 26596000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 201.34 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -354.17 Mn |
| 10 | Prokidney | 96.00 Mn | 96.00 Mn | - | -41.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.68 Mn |
| Mar 31, 2026 | -41.68 Mn |
| Dec 31, 2025 | -32.51 Mn |
| Dec 31, 2025 | -32.51 Mn |
| Sep 30, 2025 | -26.60 Mn |
| Sep 30, 2025 | -26.60 Mn |
| Jun 30, 2025 | -31.42 Mn |
| Jun 30, 2025 | -31.42 Mn |
| Mar 31, 2025 | -29.59 Mn |
| Mar 31, 2025 | -29.59 Mn |
| Dec 31, 2024 | -24.17 Mn |
| Dec 31, 2024 | -24.17 Mn |
| Sep 30, 2024 | -29.24 Mn |
| Sep 30, 2024 | -29.24 Mn |
| Jun 30, 2024 | -38.29 Mn |
| Jun 30, 2024 | -38.29 Mn |
| Mar 31, 2024 | -34.65 Mn |
| Mar 31, 2024 | -34.65 Mn |
| Dec 31, 2023 | -25.38 Mn |
| Dec 31, 2023 | -25.38 Mn |